In order to better assess the adequacy of current Parkinson disease (PD) treatments, healthcare providers have increasingly utilized various patient-based outcome measures, such as health status (HS) and health-related quality of life (HRQoL). HS questionnaires focus on the presence of symptoms (e.g. motor dysfunction, fatigue, pain embarrassment or loneliness) and their impact on one's ability to perform various life activities (e.g. housework, bathing, communicating or leisure activities), while HRQoL instruments measure a patient's subjective experience of symptoms and satisfaction with health conditions. HRQoL differs from HS in that it gauges not only the presence and severity of functional limitations, but to what extent such restrictions actually disturb the individual. [1, 2] Multiple previous publications have aimed to assess the effect of DBS on HRQoL in patients with PD; however, all have employed questionnaires (such as the PDQ-39 and PDQL) that evaluate HS, thus providing only an approximation of HRQoL. [1, 2, 4, 5] In the present study, we analyze the impact of high frequency subthalamic nucleus (STN) deep brain stimulation (DBS) on HRQoL, using a recently validated instrument, the Questions on Life Satisfaction (QLS M ) modular questionnaire, which was specifically designed for DBS patient population. [8] Exclusion criteria were as follows: age <30 or >75 years, Mini-Mental Status Examination (MMSE) score <24 or other evidence of dementia on a comprehensive neuropsychological evaluation, medically uncontrolled psychiatric co-morbidity and medical contraindications to surgery. The final decision for implantation was made in a multidisciplinary meeting attended by a neurosurgeon, movement disorder specialists, clinical nurses, and a neuropsychologist. One hundred percent of eligible patients consented to participate in the study, but two were lost to follow-up after their baseline (pre-operative) assessment due to geographical constraints and were not included in our analysis. An additional two patients completed their first but not second follow-up assessment. All patients signed an informed consent before entering the study, and the study protocol was approved by the Baylor College of Medicine Internal Review Board for Human Research. ■ The primary finding of our study was that various aspects of HRQoL improved following STN DBS, particularly satisfaction with motor function and independence. Improvements, however, did not extend to the QLSM-A, which addresses general life issues, such as occupational function, interpersonal relationships, leisure activities, and living conditions. Importantly, no QLS M domains significantly worsened following DBS.
Introduction
In order to better assess the adequacy of current Parkinson disease (PD) treatments, healthcare providers have increasingly utilized various patient-based outcome measures, such as health status (HS) and health-related quality of life (HRQoL). HS questionnaires focus on the presence of symptoms (e.g. motor dysfunction, fatigue, pain embarrassment or loneliness) and their impact on one's ability to perform various life activities (e.g. housework, bathing, communicating or leisure activities), while HRQoL instruments measure a patient's subjective experience of symptoms and satisfaction with health conditions. HRQoL differs from HS in that it gauges not only the presence and severity of functional limitations, but to what extent such restrictions actually disturb the individual. [1, 2] Multiple previous publications have aimed to assess the effect of DBS on HRQoL in patients with PD; however, all have employed questionnaires (such as the PDQ-39 and PDQL) that evaluate HS, thus providing only an approximation of HRQoL. [1, 2, 4, 5] In the present study, we analyze the impact of high frequency subthalamic nucleus (STN) deep brain stimulation (DBS) on HRQoL, using a recently validated instrument, the Questions on Life Satisfaction (QLS M ) modular questionnaire, which was specifically designed for DBS patient population. [6] 
Discussion

Methods
Participants:
We enrolled 23 consecutive patients with PD, defined according to the UK Parkinson Disease Brain Bank criteria, [7] who underwent DBS at the Baylor College of Medicine Movement Disorders Clinic in Houston, Texas. All had an excellent response to levodopa but developed motor complications refractory to medical management and met inclusion criteria for STN DBS, as per the recommendations of the CAPSIT-PD panel. [8] Exclusion criteria were as follows: age <30 or >75 years, Mini-Mental Status Examination (MMSE) score <24 or other evidence of dementia on a comprehensive neuropsychological evaluation, medically uncontrolled psychiatric co-morbidity and medical contraindications to surgery. The final decision for implantation was made in a multidisciplinary meeting attended by a neurosurgeon, movement disorder specialists, clinical nurses, and a neuropsychologist. One hundred percent of eligible patients consented to participate in the study, but two were lost to follow-up after their baseline (pre-operative) assessment due to geographical constraints and were not included in our analysis. An additional two patients completed their first but not second follow-up assessment. All patients signed an informed consent before entering the study, and the study protocol was approved by the Baylor College of Medicine Internal Review Board for Human Research. 
Evaluation Procedures: HRQoL was prospectively assessed via an expanded version of the Questions on Life Satisfaction (QLS M ).[6] The QLS M is a validated instrument that contains modules which address general life satisfaction (QLS M -A), general health satisfaction (QLS M -G), movement disorderspecific health satisfaction (QLS M -MD) and satisfaction with DBS (QLS M -DBS). Each QLSM module is divided into two sections: one section rating the importance of various items and the other rating the satisfaction associated with each item. The QLS M -MD is comprised of 12 items, the QLSM-DBS is comprised of five items, and the QLSM-
Results
■ Several prior studies have demonstrated improvements in HS following DBS. [2, 4, 5] Following Den Oudsten and colleagues, [1, 2] we advocate distinguishing HS and HRQoL in keeping with the WHO definition of quality of life. The distinction between HS and HRQoL is of consequence because differences in life style, social support, coping mechanisms and personality traits may influence how HS variables affect HRQoL, [15, 16] and available data indicate that patients themselves view HS and HRQoL as distinct constructs. [1, 2, 17, 18] ■ The primary finding of our study was that various aspects of HRQoL improved following STN DBS, particularly satisfaction with motor function and independence. Improvements, however, did not extend to the QLSM-A, which addresses general life issues, such as occupational function, interpersonal relationships, leisure activities, and living conditions. Importantly, no QLS M domains significantly worsened following DBS.
■ We found a moderate association between HRQoL and improvements in the GDS. This finding is congruent with prior work which has shown that depression is an important indicator of HS. [17, [19] [20] [21] HRQoL was also associated with UPDRS part II scores, a measure of activities of daily living, as might be expected based upon shared content between these measures.
■ Among baseline characteristics, HRQoL correlated best with the reduction in Hoehn and Yahr score between the medically "off" and "on" states. Because the Hoehn and Yahr score is heavily influenced by balance, we hypothesize that postural instability influences movement disorder-related quality of life to a greater extent than other motor features, such as tremor. Worsening Hoehn and Yahr scores have previously been shown to negatively impact HS. [15, 20] Tables 1 and 2. ■ STN DBS produced significant improvements in LFADLDS and UPDRS part II, III and IV scores as well as general health (QLS M -G) and movement disorder health (QLS M -MD) satisfaction (Table 2) . No items on the general life satisfaction module (QLS M -A) changed significantly following surgery. Weighted scores on the DBS module of the QLS M showed high satisfaction (Table 2) , which remained stable between the two post-operative assessments (student's t-test, P=0.45).
■ The difference in preoperative Hoehn and Yahr scores between the medically "off" and "on" states correlated with improvement in the QLSM-MD summary score (r = 0.72, P = 0.0005). No other baseline variable predicted long-term improvement in HRQoL. We also assessed the relationship between HRQoL and changes in clinical parameters following surgery. HRQoL benefits correlated with the postoperative improvements in the UPDRS part II (r = -0.59, P = 0.046) and the GDS (r = -0.47, P = 0.007). 
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